Ondena (BioDeep_00000230877)

 

Secondary id: BioDeep_00000858570

PANOMIX_OTCML-2023 Chemicals and Drugs


代谢物信息卡片


Daunorubicin hydrochloride;(8S,10S)-8-Acetyl-10-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride

化学式: C27H29NO10.HCl (563.155815)
中文名称: 盐酸佐柔比星, 盐酸柔红霉素
谱图信息: 最多检出来源 Chinese Herbal Medicine(otcml) 5.77%

分子结构信息

SMILES: CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.Cl
InChI: /m0./s1

描述信息

Daunorubicin hydrochloride appears as orange-red powder. Thin red needles decomposing at 188-190 °C. An anti-cancer drug.
Daunorubicin hydrochloride is an anthracycline.
Daunorubicin Hydrochloride is the hydrochloride salt of an anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin. Daunorubicin exhibits cytotoxic activity through topoisomerase-mediated interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein synthesis.
A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic
C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
D004791 - Enzyme Inhibitors
Daunorubicin (Daunomycin) hydrochloride is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin hydrochloride inhibits DNA and RNA synthesis. Daunorubicin hydrochloride is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin hydrochloride is also an anthracycline antibiotic. Daunorubicin hydrochloride can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor[1][2][4][5].

同义名列表

78 个代谢物同义名

Daunorubicin hydrochloride;(8S,10S)-8-Acetyl-10-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride; (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride; (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride; (8S,10S)-8-acetyl-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride; 5,12-NAPHTHACENEDIONE, 8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL))OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, (8S-CIS)-, HYDROCHLORIDE; 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl))oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride; 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride; 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S,10S)-; 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-; 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trhydroxy-1-methoxy-, hydrochloride, (8S,10S)-; (1S,3S)-3-ACETYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSIDE HYDROCHLORIDE; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride; (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyransoyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride; (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride; (2S,4S)-2-Acetyl-4-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-2,5,12-trihydroxy-7-methoxy-1,2,3,4-tetrahydrotetracene-6,11-dione monohydrochloride; (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside hydrochloride; L-lyxo-Hexopyranoside, 3beta-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,alpha-,hydrochloride; Daunorubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard; Daunorubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard; Daunorubicin hydrochloride, meets USP testing specifications; DAUNORUBICIN HYDROCHLORIDE [USP MONOGRAPH]; DAUNORUBICIN HYDROCHLORIDE (USP MONOGRAPH); Daunorubicin hydrochloride [USAN:USP:JAN]; DAUNORUBICIN HYDROCHLORIDE (EP MONOGRAPH); DAUNORUBICIN HYDROCHLORIDE [USP IMPURITY]; DAUNORUBICIN HYDROCHLORIDE (USP IMPURITY); Daunorubicin hydrochloride, >=90\\% (HPLC); DAUNORUBICIN HYDROCHLORIDE [EP MONOGRAPH]; Daunorubicin hydrochloride (USAN:USP:JAN); DAUNORUBICIN HYDROCHLORIDE [ORANGE BOOK]; Daunorubicin hydrochloride (JP17/USP); DAUNORUBICIN HYDROCHLORIDE [USP-RS]; DAUNORUBICIN HYDROCHLORIDE (USP-RS); DAUNORUBICIN HYDROCHLORIDE [WHO-DD]; DAUNORUBICIN HYDROCHLORIDE [VANDF]; DAUNORUBICIN HYDROCHLORIDE (MART.); DAUNORUBICIN HYDROCHLORIDE [MART.]; Daunorubicin HCl (Daunomycin HCl); DAUNORUBICIN HYDROCHLORIDE [USAN]; DAUNORUBICIN HYDROCHLORIDE [JAN]; DAUNORUBICIN HYDROCHLORIDE [MI]; Daunorubicin (as hydrochloride); Daunorubicini Hydrochloridum; Daunorubicin (Hydrochloride); daunorubicinol hydrochloride; Hydrochloride, Daunorubicin; GUGHGUXZJWAIAS-QQYBVWGSSA-N; Cloridrato de Daunorubicina; Daunorubicin Hydrochloride; Rubidomycin hydrochloride; Daunomycin, hydrochloride; Daunomycin hydrochloride; Daunomycin chlorohydrate; Daunorubicin HCl- Bio-X; Dauno Rubidomycine; Dauno-Rubidomycine; Daunorubicin.HCl; DAUNORUBICIN HCL; Daunorubicin,(S); Cerubidine (TN); C27H29NO10.HCl; Daunomycin HCL; Daunoblastine; Daunoblastina; Tox21_201159; Daunorubicin; Daunoblastin; Rubidomycin; Daunomycin; Cerubidine; Rubomycin; DaunoXome; AI3-44887; Rubilem; Ondena; Daunomycin (hydrochloride); RP 13057 (hydrochloride); Rubidomycin (hydrochloride)



数据库引用编号

10 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Ioannis Isaioglou, Gloria Lopez-Madrigal, Jasmeen S Merzaban. A fast, easy, cost-free method to remove excess dye or drug from small extracellular vesicle solution. PloS one. 2024; 19(5):e0301761. doi: 10.1371/journal.pone.0301761. [PMID: 38718025]
  • Yuanyuan Zhu, Wei Zhang, Jing Chen. Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles. Drug design, development and therapy. 2023; 17(?):1-13. doi: 10.2147/dddt.s387246. [PMID: 36636745]
  • Qi Liu, Lijun Luo, Xiaofeng Gao, Di Zhang, Xinqian Feng, Peng Yang, Hui Li, Shengjun Mao. Co-Delivery of Daunorubicin and Homoharringtonine in Folic Acid Modified-Liposomes for Enhancing Therapeutic Effect on Acute Myeloid Leukemia. Journal of pharmaceutical sciences. 2023 01; 112(1):123-131. doi: 10.1016/j.xphs.2022.04.014. [PMID: 35469834]
  • Hamad Alrbyawi, Sai H S Boddu, Ishwor Poudel, Manjusha Annaji, Nur Mita, Robert D Arnold, Amit K Tiwari, R Jayachandra Babu. Cardiolipin for Enhanced Cellular Uptake and Cytotoxicity of Thermosensitive Liposome-Encapsulated Daunorubicin toward Breast Cancer Cell Lines. International journal of molecular sciences. 2022 Oct; 23(19):. doi: 10.3390/ijms231911763. [PMID: 36233061]
  • Emmanuel Gyan, Arnaud Pigneux, Mathilde Hunault, Pierre Peterlin, Martin Carré, Jacques-Olivier Bay, Caroline Bonmati, Maria-Pilar Gallego-Hernanz, Bruno Lioure, Philippe Bertrand, Nicolas Vallet, David Ternant, François Darrouzain, Frédéric Picou, Marie-Christine Béné, Christian Récher, Olivier Hérault. Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML. Scientific reports. 2022 06; 12(1):9748. doi: 10.1038/s41598-022-13626-y. [PMID: 35697729]
  • Sha Li, Shi Zeng, Bo-Ping Wei, Qiang Wu, Chang Liu, Pei-Ying Song. Determination of free and encapsulated cytarabine and daunorubicin in rat plasma after intravenous administration of liposomal formulation using ultra-high performance liquid chromatography tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2022 Jun; 1200(?):123275. doi: 10.1016/j.jchromb.2022.123275. [PMID: 35551041]
  • Riya Sinha, Arunavo Chatterjee, Pradipta Purkayastha. Graphene Quantum Dot Assisted Translocation of Daunomycin through an Ordered Lipid Membrane: A Study by Fluorescence Lifetime Imaging Microscopy and Resonance Energy Transfer. The journal of physical chemistry. B. 2022 02; 126(6):1232-1241. doi: 10.1021/acs.jpcb.1c09376. [PMID: 35129981]
  • Zuzana Pokorná, Petra Kollárová-Brázdová, Olga Lenčová-Popelová, Eduard Jirkovský, Jan Kubeš, Yvona Mazurová, Michaela Adamcová, Magdalena Holečková, Vladimír Palička, Tomáš Šimůnek, Martin Štěrba. Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up. Clinical science (London, England : 1979). 2022 01; 136(1):139-161. doi: 10.1042/cs20210836. [PMID: 34878093]
  • Claire Amaris Hobson, Lucile Vigué, Mélanie Magnan, Benoit Chassaing, Sabrine Naimi, Benoit Gachet, Pauline Claraz, Thomas Storme, Stephane Bonacorsi, Olivier Tenaillon, André Birgy. A Microbiota-Dependent Response to Anticancer Treatment in an In Vitro Human Microbiota Model: A Pilot Study With Hydroxycarbamide and Daunorubicin. Frontiers in cellular and infection microbiology. 2022; 12(?):886447. doi: 10.3389/fcimb.2022.886447. [PMID: 35719352]
  • Mélanie Donnette, Mourad Hamimed, Joseph Ciccolini, Yael Berda-Haddad, Elise Kaspi, Geoffroy Venton, Bruno Lacarelle, Regis Costello, L''Houcine Ouafik, Laure Farnault, Raphaelle Fanciullino. Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351. Journal of controlled release : official journal of the Controlled Release Society. 2021 10; 338(?):244-252. doi: 10.1016/j.jconrel.2021.08.023. [PMID: 34416320]
  • Danyang Wu, Xiaoxuan Lu, Xiaojing Yan, Ran Gao. Case report: Rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations. Diagnostic pathology. 2021 Aug; 16(1):82. doi: 10.1186/s13000-021-01141-z. [PMID: 34465355]
  • Petra Kollárová-Brázdová, Olga Lenčová-Popelová, Galina Karabanovich, Júlia Kocúrová-Lengvarská, Jan Kubeš, Nela Váňová, Yvona Mazurová, Michaela Adamcová, Anna Jirkovská, Magdalena Holečková, Tomáš Šimůnek, Petra Štěrbová-Kovaříková, Jaroslav Roh, Martin Štěrba. Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo. Clinical science (London, England : 1979). 2021 08; 135(15):1897-1914. doi: 10.1042/cs20210311. [PMID: 34318878]
  • Satya Prakash Yadav, Teena Wadhwa, Dhwanee Thakkar, Rohit Kapoor, Neha Rastogi, Smita Sarma. COVID-19 reinfection in two children with cancer. Pediatric hematology and oncology. 2021 05; 38(4):403-405. doi: 10.1080/08880018.2020.1855276. [PMID: 33625290]
  • W-Y Chen, Z-X Fang, X-D Lv, Q-H Zhou, M Yao, M Deng. Prediction of potential therapeutic drugs against SARS-CoV-2 by using Connectivity Map based on transcriptome data. European review for medical and pharmacological sciences. 2021 04; 25(7):3122-3131. doi: 10.26355/eurrev_202104_25567. [PMID: 33877681]
  • Annette Demmer, Hubert Thole, Manfred Raida, Burkhard Tümmler. Lysine 268 adjacent to transmembrane helix 5 of hamster P-glycoprotein is the major photobinding site of iodomycin in CHO B30 cells. FEBS open bio. 2021 04; 11(4):1084-1092. doi: 10.1002/2211-5463.13112. [PMID: 33565718]
  • Kumuda C Das, Harish Muniyappa, Venkatesh Kundumani-Sridharan, Jaganathan Subramani. Thioredoxin Decreases Anthracycline Cardiotoxicity, But Sensitizes Cancer Cell Apoptosis. Cardiovascular toxicology. 2021 02; 21(2):142-151. doi: 10.1007/s12012-020-09605-2. [PMID: 32880787]
  • Olga Maliszewska, Natalia Treder, IIona Olędzka, Piotr Kowalski, Natalia Miękus, Tomasz Bączek, Wojciech Rodzaj, Ewa Bień, Małgorzata Anna Krawczyk, Alina Plenis. Sensitive Analysis of Idarubicin in Human Urine and Plasma by Liquid Chromatography with Fluorescence Detection: An Application in Drug Monitoring. Molecules (Basel, Switzerland). 2020 Dec; 25(24):. doi: 10.3390/molecules25245799. [PMID: 33316898]
  • Milena Locci de Oliveira, Adriana Rocha, Glauco Henrique Balthazar Nardotto, Leandro Francisco Pippa, Belinda Pinto Simões, Vera Lucia Lanchote. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of pharmaceutical and biomedical analysis. 2020 Nov; 191(?):113576. doi: 10.1016/j.jpba.2020.113576. [PMID: 32889347]
  • Jiaoyang Zhang, Lingli Zhou, Yu Zhang, Haibing He, Tian Yin, Jingxin Gou, Yanjiao Wang, Xing Tang. Contrastive Studies of Cytarabine/Daunorubicin Dual-Loaded Liposomes Prepared by pH Gradient and Cu2+ Gradient Method. AAPS PharmSciTech. 2020 Nov; 21(8):325. doi: 10.1208/s12249-020-01867-x. [PMID: 33206247]
  • Qi Wang, Paul Tardi, Nicole Sadowski, Sherwin Xie, Dennis Heller, Lawrence Mayer. Pharmacokinetics, drug metabolism, and tissue distribution of CPX-351 in animals. Nanomedicine : nanotechnology, biology, and medicine. 2020 11; 30(?):102275. doi: 10.1016/j.nano.2020.102275. [PMID: 32750494]
  • Huan Zhou, Li-Xiang Fu, Li Li, Yan-Yan Chen, Hong-Qing Zhu, Jin-Ling Zhou, Mei-Xian Lv, Ri-Zhi Gan, Xuan-Xuan Zhang, Gang Liang. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression. Journal of ethnopharmacology. 2020 Oct; 261(?):113118. doi: 10.1016/j.jep.2020.113118. [PMID: 32621953]
  • Lia Phillips, Jovana Pavisic, Dominder Kaur, N Valerio Dorrello, Larisa Broglie, Nobuko Hijiya. Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia. Blood advances. 2020 09; 4(18):4358-4361. doi: 10.1182/bloodadvances.2020002745. [PMID: 32926122]
  • Fereidoon Rahmani, Mohammad-Reza Milani Hosseini, Ali Es-Haghi, Afsaneh Mollahosseini. A 96-Monolithic inorganic hollow fiber array as a new geometry for high throughput solid-phase microextraction of doxorubicin in water and human urine samples coupled with liquid chromatography-tandem mass spectrometry. Journal of chromatography. A. 2020 Sep; 1627(?):461413. doi: 10.1016/j.chroma.2020.461413. [PMID: 32823111]
  • Qiu-Jin Yang, Jie Zheng, Fu-Tao Dang, Yue-Meng Wan, Jing Yang. Acute pancreatitis induced by combination chemotherapy used for the treatment of acute myeloid leukemia: A case report. Medicine. 2020 Aug; 99(35):e21848. doi: 10.1097/md.0000000000021848. [PMID: 32871908]
  • Wencheng Xu, Xiaoqin Wang, Shuhe Chen, Hongguang Wu, Sachiko Tanaka, Kenji Onda, Kentaro Sugiyama, Haruki Yamada, Toshihiko Hirano. Tetrandrine enhances glucocorticoid receptor translocation possibly via inhibition of P-glycoprotein in daunorubicin-resistant human T lymphoblastoid leukemia cells. European journal of pharmacology. 2020 Aug; 881(?):173232. doi: 10.1016/j.ejphar.2020.173232. [PMID: 32525004]
  • Qingwei Nong, Cong Zhang, Qinghao Liu, Rui Xie, Min Dong. Effect of daunorubicin on acute promyelocytic leukemia cells using nuclear magnetic resonance spectroscopy-based metabolomics. Environmental toxicology and pharmacology. 2020 Aug; 78(?):103382. doi: 10.1016/j.etap.2020.103382. [PMID: 32344291]
  • Nadine Farah, Richard Burt, Amr R Ibrahim, Robert Baker, Panagiotis D Kottaridis. Concerns about how to use established minimal residual disease monitoring in the treatment of NPM1-mutant acute myeloid leukaemia (AML) following reduced intensity chemotherapy protocols for AML given as a result of the COVID-19 pandemic. British journal of haematology. 2020 08; 190(4):e208-e210. doi: 10.1111/bjh.16985. [PMID: 32609881]
  • Masuho Saburi, Masao Ogata, Yasuhiro Soga, Kazuhito Itani, Kazuhiro Kohno, Toshiyuki Nakayama. L-asparaginase-induced Parotitis in an Elderly Patient with Acute Lymphoblastic Leukemia. Internal medicine (Tokyo, Japan). 2020 Jul; 59(14):1745-1748. doi: 10.2169/internalmedicine.4335-19. [PMID: 32296003]
  • Andrea Angelo Pierluigi Tripodi, Ivan Ranđelović, Beáta Biri-Kovács, Bálint Szeder, Gábor Mező, József Tóvári. In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery. Pathology oncology research : POR. 2020 Jul; 26(3):1879-1892. doi: 10.1007/s12253-019-00773-3. [PMID: 31820302]
  • Xue-Min Yao, Feng-Ju Niu, Liang Kong, Fu-Yi Cai, Ming Jing, Min Fu, Jing-Jing Liu, Si-Yu He, Lu Zhang, Xin-Ze Liu, Rui-Jun Ju, Xue-Tao Li. GGP modified daunorubicin plus dioscin liposomes inhibit breast cancer by suppressing epithelial-mesenchymal transition. Drug development and industrial pharmacy. 2020 Jun; 46(6):916-930. doi: 10.1080/03639045.2020.1763397. [PMID: 32362146]
  • Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Caleb A Class, Koji Sasaki, Farhad Ravandi, Jorge E Cortes, Naval Daver, Koichi Takahashi, Nicholas J Short, Courtney D DiNardo, Elias Jabbour, Gautam Borthakur, Kiran Naqvi, Ghayas C Issa, Marina Konopleva, Joseph D Khoury, Mark Routbort, Sherry Pierce, Kim-Anh Do, Carlos Bueso-Ramos, Keyur Patel, Hagop Kantarjian, Guillermo Garcia-Manero, Tapan M Kadia. Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy. American journal of hematology. 2020 06; 95(6):612-622. doi: 10.1002/ajh.25769. [PMID: 32112433]
  • Mirza Muhammad Faran Ashraf Baig, Wing-Fu Lai, Reyaj Mikrani, Mehreen Jabeen, Muhammad Naveed, Muhammad Abbas, Muhammad Asim Farooq, Anam Ahsan, Said Abasse Kassim, Ghulam Jilany Khan, Muhammad Tayyab Ansari. Synthetic NRG-1 functionalized DNA nanospindels towards HER2/neu targets for in vitro anti-cancer activity assessment against breast cancer MCF-7 cells. Journal of pharmaceutical and biomedical analysis. 2020 Apr; 182(?):113133. doi: 10.1016/j.jpba.2020.113133. [PMID: 32004770]
  • P H Nguyen, K P Sigdel, K G Schaefer, G A K Mensah, G M King, A G Roberts. The effects of anthracycline drugs on the conformational distribution of mouse P-glycoprotein explains their transport rate differences. Biochemical pharmacology. 2020 04; 174(?):113813. doi: 10.1016/j.bcp.2020.113813. [PMID: 31954717]
  • Min Fu, Wei Tang, Jing-Jing Liu, Xiao-Qing Gong, Liang Kong, Xue-Min Yao, Ming Jing, Fu-Yi Cai, Xue-Tao Li, Rui-Jun Ju. Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer. Journal of drug targeting. 2020 03; 28(3):245-258. doi: 10.1080/1061186x.2019.1656725. [PMID: 31462111]
  • Xin Zeng, Jie Sun, Suping Li, Jiyun Shi, Han Gao, Wei Sun Leong, Yiqi Wu, Minghui Li, Chengxin Liu, Ping Li, Jing Kong, Yi-Zhou Wu, Guangjun Nie, Yuming Fu, Gen Zhang. Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agent. Nature communications. 2020 Jan; 11(1):567. doi: 10.1038/s41467-019-14131-z. [PMID: 31992692]
  • Erfaneh Firouzi Niaki, Thibaut Van Acker, László Imre, Péter Nánási, Szabolcs Tarapcsák, Zsolt Bacsó, Frank Vanhaecke, Gábor Szabó. Interactions of Cisplatin and Daunorubicin at the Chromatin Level. Scientific reports. 2020 01; 10(1):1107. doi: 10.1038/s41598-020-57702-7. [PMID: 31980698]
  • Wooil Choi, Mi Young Heo, Sang Yong Kim, Ji-Hyang Wee, Yang-Hoon Kim, Jiho Min. Encapsulation of daunorubicin into Saccharomyces cerevisiae-derived lysosome as drug delivery vehicles for acute myeloid leukemia (AML) treatment. Journal of biotechnology. 2020 Jan; 308(?):118-123. doi: 10.1016/j.jbiotec.2019.12.008. [PMID: 31846628]
  • Yanhui Liu, Pingchong Lei, Hong Qiao, Kai Sun, Xiling Lu, Fengchang Bao, Runhong Yu, Cheng Lian, Yao Li, Wei Chen, Fei Xue. MicroRNA-33b regulates sensitivity to daunorubicin in acute myelocytic leukemia by regulating eukaryotic translation initiation factor 5A-2. Journal of cellular biochemistry. 2020 01; 121(1):385-393. doi: 10.1002/jcb.29192. [PMID: 31222822]
  • Shili Sun, Huixi Zou, Lin Li, Qi Liu, Ning Ding, Lili Zeng, Hui Li, Shengjun Mao. CD123/CD33 dual-antibody modified liposomes effectively target acute myeloid leukemia cells and reduce antigen-negative escape. International journal of pharmaceutics. 2019 Sep; 568(?):118518. doi: 10.1016/j.ijpharm.2019.118518. [PMID: 31319147]
  • Zuzana Pokorna, Eduard Jirkovsky, Marketa Hlavackova, Hana Jansova, Anna Jirkovska, Olga Lencova-Popelova, Petra Brazdova, Jan Kubes, Dita Sotakova-Kasparova, Yvona Mazurova, Michaela Adamcova, Lucie Vostatkova, Kristyna Holzerova, Frantisek Kolar, Tomas Simunek, Martin Sterba. In vitro and in vivo investigation of cardiotoxicity associated with anticancer proteasome inhibitors and their combination with anthracycline. Clinical science (London, England : 1979). 2019 08; 133(16):1827-1844. doi: 10.1042/cs20190139. [PMID: 31409729]
  • Tara L Lin, Laura F Newell, Robert K Stuart, Laura C Michaelis, Eric Rubenstein, Helen S Pentikis, Timothy Callahan, Donna Alvarez, Barry D Liboiron, Lawrence D Mayer, Qi Wang, Kamalika Banerjee, Arthur C Louie. A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias. Cancer chemotherapy and pharmacology. 2019 07; 84(1):163-173. doi: 10.1007/s00280-019-03856-9. [PMID: 31098682]
  • Su-Fern Tan, Wendy Dunton, Xin Liu, Todd E Fox, Samy A F Morad, Dhimant Desai, Kenichiro Doi, Mark R Conaway, Shantu Amin, David F Claxton, Hong-Gang Wang, Mark Kester, Myles C Cabot, David J Feith, Thomas P Loughran. Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation. Journal of lipid research. 2019 06; 60(6):1078-1086. doi: 10.1194/jlr.m091876. [PMID: 30962310]
  • Hong-Lin Xiang, Yu Chen, Jia-Wei Wang, Hui-Jie Wang, Xiao-Feng Gao, Hui Li, Sheng-Jun Mao. Enhancing cytotoxicity of daunorubicin on drug-resistant leukaemia cells with microparticle-mediated drug delivery system. Journal of microencapsulation. 2019 May; 36(3):291-304. doi: 10.1080/02652048.2019.1626926. [PMID: 31151361]
  • Qi Wang, Kamalika Banerjee, Grygoriy Vasilinin, J F Marier, Jacqueline A Gibbons. Population Pharmacokinetics and Exposure-Response Analyses for CPX-351 in Patients With Hematologic Malignancies. Journal of clinical pharmacology. 2019 05; 59(5):748-762. doi: 10.1002/jcph.1366. [PMID: 30566230]
  • Niyaz Ahmad, Rizwan Ahmad, Md Aftab Alam, Farhan Jalees Ahmad, Mohd Amir, Faheem Hyder Pottoo, Md Sarafroz, Mohammed Jafar, Khalid Umar. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles. International journal of biological macromolecules. 2019 May; 128(?):825-838. doi: 10.1016/j.ijbiomac.2019.01.142. [PMID: 30690115]
  • Mojtaba Ghadiany, Mahdi Tabarraee, Sina Salari, Shirin Haghighi, Hamid Rezvani, Seyedeh Najmeh Ghasemi, Hamidreza Karimi-Sari. Adding Oral Pioglitazone to Standard Induction Chemotherapy of Acute Myeloid Leukemia: A Randomized Clinical Trial. Clinical lymphoma, myeloma & leukemia. 2019 04; 19(4):206-212. doi: 10.1016/j.clml.2019.01.006. [PMID: 30770307]
  • Yuanyuan Wang, Min Fu, Jingjing Liu, Yining Yang, Yibin Yu, Jinyu Li, Weisan Pan, Lei Fan, Guiru Li, Xuetao Li, Xiaobo Wang. Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer. International journal of nanomedicine. 2019; 14(?):4071-4090. doi: 10.2147/ijn.s194304. [PMID: 31239668]
  • Michela Codini, Carmela Conte, Samuela Cataldi, Cataldo Arcuri, Andrea Lazzarini, Maria Rachele Ceccarini, Federica Patria, Alessandro Floridi, Carmen Mecca, Francesco Saverio Ambesi-Impiombato, Tommaso Beccari, Francesco Curcio, Elisabetta Albi. Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells. International journal of molecular sciences. 2018 Nov; 19(11):. doi: 10.3390/ijms19113424. [PMID: 30388783]
  • Rui-Jun Ju, Lan Cheng, Xiao Qiu, Shuang Liu, Xiao-Li Song, Xiao-Ming Peng, Teng Wang, Cui-Qing Li, Xue-Tao Li. Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels. Journal of drug targeting. 2018 11; 26(9):793-805. doi: 10.1080/1061186x.2018.1428809. [PMID: 29334266]
  • Olga Maliszewska, Alina Plenis, Ilona Olędzka, Piotr Kowalski, Natalia Miękus, Ewa Bień, Małgorzata Anna Krawczyk, Elżbieta Adamkiewicz-Drożynska, Tomasz Bączek. Optimization of LC method for the quantification of doxorubicin in plasma and urine samples in view of pharmacokinetic, biomedical and drug monitoring therapy studies. Journal of pharmaceutical and biomedical analysis. 2018 Sep; 158(?):376-385. doi: 10.1016/j.jpba.2018.06.031. [PMID: 29936377]
  • Natasha K A van Eijkelenburg, Mareike Rasche, Essam Ghazaly, Michael N Dworzak, Thomas Klingebiel, Claudia Rossig, Guy Leverger, Jan Stary, Eveline S J M De Bont, Dana A Chitu, Yves Bertrand, Benoit Brethon, Brigitte Strahm, Inge M van der Sluis, Gertjan J L Kaspers, Dirk Reinhardt, C Michel Zwaan. Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study. Haematologica. 2018 09; 103(9):1484-1492. doi: 10.3324/haematol.2017.187153. [PMID: 29773602]
  • Hai-Tao Li, Shu-Yan Zhao, Zhi-Yu Liu, Jin-Xiao Hou, Ying-Mei Zhang, Dong-Guang Yang, Ping Wang. [Effect of Daunorubicin on Release and Procoagulant Activity of Microparticles Derived from Acute Promyelocytic Leukemia Cells]. Zhongguo shi yan xue ye xue za zhi. 2018 Aug; 26(4):972-977. doi: 10.7534/j.issn.1009-2137.2018.04.005. [PMID: 30111393]
  • Chintan Vyas, Sandeep Jain, Gauri Kapoor, Anurag Mehta, Parul Takkar Chugh. Experience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity. Pediatric hematology and oncology. 2018 Aug; 35(5-6):331-340. doi: 10.1080/08880018.2018.1538277. [PMID: 30488741]
  • Roberta Spadaccini, Hundeep Kaur, Johanna Becker-Baldus, Clemens Glaubitz. The effect of drug binding on specific sites in transmembrane helices 4 and 6 of the ABC exporter MsbA studied by DNP-enhanced solid-state NMR. Biochimica et biophysica acta. Biomembranes. 2018 Apr; 1860(4):833-840. doi: 10.1016/j.bbamem.2017.10.017. [PMID: 29069570]
  • Song Wha Chae, Jaeok Lee, Jung Hyun Park, Youngjoo Kwon, Younghwa Na, Hwa Jeong Lee. Intestinal P-glycoprotein inhibitors, benzoxanthone analogues. The Journal of pharmacy and pharmacology. 2018 Feb; 70(2):234-241. doi: 10.1111/jphp.12832. [PMID: 29238994]
  • Yi-Zhou Wu, Jie Sun, Haowen Yang, Xiaohui Zhao, Dacheng He, Maomao Pu, Gen Zhang, Nongyue He, Xin Zeng. Biosynthetic Mechanism of Luminescent ZnO Nanocrystals in the Mammalian Blood Circulation and Their Functionalization for Tumor Therapy. ACS applied materials & interfaces. 2018 Jan; 10(1):105-113. doi: 10.1021/acsami.7b13691. [PMID: 29281248]
  • Rui-Jun Ju, Lan Cheng, Xiao-Ming Peng, Teng Wang, Cui-Qing Li, Xiao-Li Song, Shuang Liu, Jian-Ping Chao, Xue-Tao Li. Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer. Artificial cells, nanomedicine, and biotechnology. 2018; 46(sup1):616-628. doi: 10.1080/21691401.2018.1433187. [PMID: 29381101]
  • Soumya Das, Vikram Kumar, Esha Jafa, Abhishekh Basavarajegowda, Smita Kayal. Complete disappearance of ABO antigen-a cause of ABO discrepancy. Transfusion. 2018 01; 58(1):5-6. doi: 10.1111/trf.14231. [PMID: 29314104]
  • Ana Catarina Alves, Cláudia Nunes, José Lima, Salette Reis. Daunorubicin and doxorubicin molecular interplay with 2D membrane models. Colloids and surfaces. B, Biointerfaces. 2017 Dec; 160(?):610-618. doi: 10.1016/j.colsurfb.2017.09.058. [PMID: 29028609]
  • Asma Saljooqi, Tayebeh Shamspur, Ali Mostafavi. Ag-4-ATP-MWCNT electrode modified with dsDNA as label-free electrochemical sensor for the detection of daunorubicin anticancer drug. Bioelectrochemistry (Amsterdam, Netherlands). 2017 Dec; 118(?):161-167. doi: 10.1016/j.bioelechem.2017.08.003. [PMID: 28843934]
  • Weihua Li, Min Lu, Yanhong Zhang, Danqin Xia, Zebin Chen, Linhua Wang, Nina Yin, Zhigang Wang. Puerarin attenuates the daunorubicin-induced apoptosis of H9c2 cells by activating the PI3K/Akt signaling pathway via the inhibition of Ca2+ influx. International journal of molecular medicine. 2017 Dec; 40(6):1889-1894. doi: 10.3892/ijmm.2017.3186. [PMID: 29039532]
  • A J Innes, B H Mullish, F Fernando, G Adams, J R Marchesi, J F Apperley, E Brannigan, F Davies, J Pavlů. Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality. Bone marrow transplantation. 2017 10; 52(10):1452-1454. doi: 10.1038/bmt.2017.151. [PMID: 28714946]
  • Shuang Liu, Shi-Meng Zhang, Rui-Jun Ju, Yao Xiao, Xin Wang, Xiao-Li Song, Li-Yan Gu, Lan Cheng, Xue-Tao Li, Gui-Rong Chen. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2017 Aug; 106(?):185-197. doi: 10.1016/j.ejps.2017.06.002. [PMID: 28583810]
  • Ana Catarina Alves, Daniela Ribeiro, Miguel Horta, José L F C Lima, Cláudia Nunes, Salette Reis. A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity. Journal of the Royal Society, Interface. 2017 08; 14(133):. doi: 10.1098/rsif.2017.0408. [PMID: 28855387]
  • Shuang Liu, Xiao-Li Song, Yan-Hong Wang, Xiao-Min Wang, Yao Xiao, Xin Wang, Lan Cheng, Xue-Tao Li. The efficacy of WGA modified daunorubicin anti-resistant liposomes in treatment of drug-resistant MCF-7 breast cancer. Journal of drug targeting. 2017 Jul; 25(6):541-553. doi: 10.1080/1061186x.2017.1298602. [PMID: 28277825]
  • Zhen Huang, Juxiang Wang, Jiangchao Qian, Yuan Li, Zhisheng Xu, Min Chen, Hongfei Tong. Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia. Molecular medicine reports. 2017 Jun; 15(6):3493-3498. doi: 10.3892/mmr.2017.6470. [PMID: 28440407]
  • Ana Catarina Alves, Daniela Ribeiro, Miguel Horta, José L F C Lima, Cláudia Nunes, Salette Reis. The daunorubicin interplay with mimetic model membranes of cancer cells: A biophysical interpretation. Biochimica et biophysica acta. Biomembranes. 2017 May; 1859(5):941-948. doi: 10.1016/j.bbamem.2017.01.034. [PMID: 28153496]
  • Jen-Fen Fu, Sung-Tzu Liang, Ying-Jung Huang, Kung-Hao Liang, Tzung-Hai Yen, Der-Cherng Liang, Lee-Yung Shih. Cooperation of MLL/AF10(OM-LZ) with PTPN11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model. International journal of cancer. 2017 Mar; 140(5):1159-1172. doi: 10.1002/ijc.30515. [PMID: 27859216]
  • Max J Gordon, Paul Tardi, Marc M Loriaux, Stephen E Spurgeon, Elie Traer, Tibor Kovacsovics, Lawrence D Mayer, Jeffrey W Tyner. CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation. Leukemia research. 2017 02; 53(?):39-49. doi: 10.1016/j.leukres.2016.12.002. [PMID: 28013106]
  • Sven Marcel Schmitt, Katja Stefan, Michael Wiese. Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1). Biochimica et biophysica acta. Biomembranes. 2017 Jan; 1859(1):69-79. doi: 10.1016/j.bbamem.2016.10.017. [PMID: 27810353]
  • Lia Gore, Timothy J Triche, Jason E Farrar, Daniel Wai, Christophe Legendre, Gerald C Gooden, Winnie S Liang, John Carpten, David Lee, Frank Alvaro, Margaret E Macy, Carola Arndt, Philip Barnette, Todd Cooper, Laura Martin, Aru Narendran, Jessica Pollard, Soheil Meshinchi, Jessica Boklan, Robert J Arceci, Bodour Salhia. A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML. Clinical epigenetics. 2017; 9(?):108. doi: 10.1186/s13148-017-0411-x. [PMID: 29034009]
  • Yasuhiro Ichikawa, Alice E Zemljic-Harpf, Zheng Zhang, M Dan McKirnan, Ana Maria Manso, Robert S Ross, H Kirk Hammond, Hemal H Patel, David M Roth. Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits. PloS one. 2017; 12(5):e0177660. doi: 10.1371/journal.pone.0177660. [PMID: 28498861]
  • Olga Lenčová-Popelová, Hana Jansová, Eduard Jirkovský, Jan Bureš, Anna Jirkovská-Vávrová, Yvona Mazurová, Petra Reimerová, Lucie Vostatková, Michaela Adamcová, Miloš Hroch, Zuzana Pokorná, Petra Kovaříková, Tomáš Šimůnek, Martin Štěrba. Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?. Toxicology. 2016 Nov; 372(?):52-63. doi: 10.1016/j.tox.2016.11.002. [PMID: 27816693]
  • Savitha Varatharajan, John C Panetta, Ajay Abraham, Sreeja Karathedath, Ezhilpavai Mohanan, Kavitha M Lakshmi, Nancy Arthur, Vivi M Srivastava, Sandeep Nemani, Biju George, Alok Srivastava, Vikram Mathews, Poonkuzhali Balasubramanian. Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia. Cancer chemotherapy and pharmacology. 2016 Nov; 78(5):1051-1058. doi: 10.1007/s00280-016-3166-8. [PMID: 27738808]
  • Zhijun Wang, Ranadheer Ravula, Leming Shi, Yunjie Song, Steven Yeung, Mandy Liu, Bernard Lau, Jijun Hao, Jeffrey Wang, Christopher Wai Kei Lam, Moses Sing Sum Chow, Ying Huang. Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms. Oncotarget. 2016 09; 7(38):61246-61261. doi: 10.18632/oncotarget.10868. [PMID: 27487134]
  • Eilon Krashin, Osnat J Dolberg, Ilana Hellmann, Alwin D R Huitema, Hilde Rosing, Martin Ellis. Cytosine arabinoside and daunorubicin induction therapy in a patient with acute myeloid leukemia on chronic hemodialysis. Anti-cancer drugs. 2016 09; 27(8):800-3. doi: 10.1097/cad.0000000000000382. [PMID: 27254285]
  • Min-Chao Liu, Shu-Fang Jin, Min Zheng, Yan Wang, Peng-Liang Zhao, Ding-Tong Tang, Jiong Chen, Jia-Qi Lin, Xia-Hong Wang, Ping Zhao. Daunomycin-loaded superparamagnetic iron oxide nanoparticles: Preparation, magnetic targeting, cell cytotoxicity, and protein delivery research. Journal of biomaterials applications. 2016 08; 31(2):261-72. doi: 10.1177/0885328216654425. [PMID: 27288463]
  • Vengadeshprabhu Karuppagounder, Somasundaram Arumugam, Rajarajan A Thandavarayan, Remya Sreedhar, Vijayasree V Giridharan, Rejina Afrin, Meilei Harima, Shizuki Miyashita, Masanori Hara, Kenji Suzuki, Masahiko Nakamura, Kazuyuki Ueno, Kenichi Watanabe. Curcumin alleviates renal dysfunction and suppresses inflammation by shifting from M1 to M2 macrophage polarization in daunorubicin induced nephrotoxicity in rats. Cytokine. 2016 08; 84(?):1-9. doi: 10.1016/j.cyto.2016.05.001. [PMID: 27203664]
  • Seby Elsy Varghese, Mayur K Fariya, Gopal Singh Rajawat, Frank Steiniger, Alfred Fahr, Mangal S Nagarsenker. Lecithin and PLGA-based self-assembled nanocomposite, Lecithmer: preparation, characterization, and pharmacokinetic/pharmacodynamic evaluation. Drug delivery and translational research. 2016 08; 6(4):342-53. doi: 10.1007/s13346-016-0314-y. [PMID: 27371394]
  • Wei-Yu Zhao, Cheng-Xiang Zhang, Lei Liu, Li-Min Mu, Fan Zeng, Rui-Jun Ju, Hong-Jun Xie, Yan Yan, Yao Zhao, Wan-Liang Lu. Construction of Functional Targeting Daunorubicin Liposomes Used for Eliminating Brain Glioma and Glioma Stem Cells. Journal of biomedical nanotechnology. 2016 07; 12(7):1404-420. doi: 10.1166/jbn.2016.2266. [PMID: 29336535]
  • Sven Marcel Schmitt, Katja Stefan, Michael Wiese. Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1). Journal of medicinal chemistry. 2016 Apr; 59(7):3018-33. doi: 10.1021/acs.jmedchem.5b01644. [PMID: 26943020]
  • Emil Andreev, Nicolas Brosseau, Euridice Carmona, Anne-Marie Mes-Masson, Dindial Ramotar. The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin. Scientific reports. 2016 Feb; 6(?):20508. doi: 10.1038/srep20508. [PMID: 26861753]
  • Olga Lenčová-Popelová, Eduard Jirkovský, Hana Jansová, Anna Jirkovská-Vávrová, Lucie Vostatková-Tichotová, Yvona Mazurová, Michaela Adamcová, Jaroslav Chládek, Miloš Hroch, Zuzana Pokorná, Vladimír Geršl, Tomáš Šimůnek, Martin Štěrba. Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane. Journal of molecular and cellular cardiology. 2016 Feb; 91(?):92-103. doi: 10.1016/j.yjmcc.2015.12.021. [PMID: 26724189]
  • Xiupei Yang, Huanhuan Gao, Fan Qian, Chuan Zhao, Xiangjun Liao. Internal standard method for the measurement of doxorubicin and daunorubicin by capillary electrophoresis with in-column double optical-fiber LED-induced fluorescence detection. Journal of pharmaceutical and biomedical analysis. 2016 Jan; 117(?):118-24. doi: 10.1016/j.jpba.2015.08.037. [PMID: 26350558]
  • Abhi Das, Gopinatha Suresh Kumar. Binding of the alkaloid aristololactam-β-D-glucoside and daunomycin to human hemoglobin: spectroscopy and calorimetry studies. Journal of biomolecular structure & dynamics. 2016; 34(4):800-13. doi: 10.1080/07391102.2015.1055304. [PMID: 26065442]
  • Claudia Stäubert, Rosanna Krakowsky, Hasanuzzaman Bhuiyan, Barbara Witek, Anna Lindahl, Oliver Broom, Anders Nordström. Increased lanosterol turnover: a metabolic burden for daunorubicin-resistant leukemia cells. Medical oncology (Northwood, London, England). 2016 Jan; 33(1):6. doi: 10.1007/s12032-015-0717-5. [PMID: 26698156]
  • Michaela Adamcova, Olga Lencova-Popelova, Eduard Jirkovsky, Yvona Mazurova, Vladimir Palicka, Fedor Simko, Vladimir Gersl, Martin Sterba. Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value. International journal of cardiology. 2015 Dec; 201(?):358-67. doi: 10.1016/j.ijcard.2015.07.103. [PMID: 26310978]
  • Trinity Vera, Ralph B D'Agostino, Jennifer H Jordan, Matthew C Whitlock, Giselle C Meléndez, Zanetta S Lamar, Mercedes Porosnicu, Herbert L Bonkovsky, Leslie B Poole, W Gregory Hundley. Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy. The American journal of cardiology. 2015 Dec; 116(11):1752-5. doi: 10.1016/j.amjcard.2015.08.042. [PMID: 26433273]
  • Lucie Zemanova, Jakub Hofman, Eva Novotna, Kamil Musilek, Tereza Lundova, Jana Havrankova, Anna Hostalkova, Jakub Chlebek, Lucie Cahlikova, Vladimír Wsol. Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment. Journal of natural products. 2015 Nov; 78(11):2666-74. doi: 10.1021/acs.jnatprod.5b00616. [PMID: 26529431]
  • Victor Sanjit Nirmalanandhan, Rose Hurren, William D Cameron, Marcela Gronda, Aisha Shamas-Din, Lidan You, Mark D Minden, Jonathan V Rocheleau, Aaron D Schimmer. Increased pressure alters plasma membrane dynamics and renders acute myeloid leukemia cells resistant to daunorubicin. Haematologica. 2015 Oct; 100(10):e406-8. doi: 10.3324/haematol.2015.129866. [PMID: 26185171]
  • Dorota Matyszewska, Karolina Brzezińska, Joanna Juhaniewicz, Renata Bilewicz. pH dependence of daunorubicin interactions with model DMPC:Cholesterol membranes. Colloids and surfaces. B, Biointerfaces. 2015 Oct; 134(?):295-303. doi: 10.1016/j.colsurfb.2015.07.001. [PMID: 26209780]
  • Vengadeshprabhu Karuppagounder, Somasundaram Arumugam, Rajarajan Amirthalingam Thandavarayan, Vigneshwaran Pitchaimani, Remya Sreedhar, Rejina Afrin, Meilei Harima, Hiroshi Suzuki, Kenji Suzuki, Masahiko Nakamura, Kazuyuki Ueno, Kenichi Watanabe. Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation. International immunopharmacology. 2015 Sep; 28(1):154-9. doi: 10.1016/j.intimp.2015.05.050. [PMID: 26072060]
  • Sahra Ali, Gail L Jones, Dominic J Culligan, Philippa J Marsden, Nigel Russell, Nicholas D Embleton, Charles Craddock. Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy. British journal of haematology. 2015 Aug; 170(4):487-95. doi: 10.1111/bjh.13554. [PMID: 26081614]
  • James W McCormick, Pia D Vogel, John G Wise. Multiple Drug Transport Pathways through Human P-Glycoprotein. Biochemistry. 2015 Jul; 54(28):4374-90. doi: 10.1021/acs.biochem.5b00018. [PMID: 26125482]
  • John F DiPersio, Harry P Erba, Richard A Larson, Selina M Luger, Martin S Tallman, Jeffrey M Brill, Gregoire Vuagniaux, Elisabeth Rouits, J Mel Sorensen, Claudio Zanna. Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study. Clinical lymphoma, myeloma & leukemia. 2015 Jul; 15(7):443-9. doi: 10.1016/j.clml.2015.02.020. [PMID: 25842225]
  • Jan Hintzpeter, Jan Hornung, Bettina Ebert, Hans-Jörg Martin, Edmund Maser. Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase--Carbonyl reductase 1. Chemico-biological interactions. 2015 Jun; 234(?):162-8. doi: 10.1016/j.cbi.2014.12.019. [PMID: 25541467]
  • Y Z Su, C B Wang, Y Zhou, N T Sun. Effects of changes in serum endostatin and fibroblast growth factor 19 on the chemotherapeutic sensitivity in acute myeloid leukemia patients. Genetics and molecular research : GMR. 2015 May; 14(2):5181-7. doi: 10.4238/2015.may.18.8. [PMID: 26125711]
  • Oliver Callies, María P Sánchez-Cañete, Francisco Gamarro, Ignacio A Jiménez, Santiago Castanys, Isabel L Bazzocchi. Restoration of Chemosensitivity in P-Glycoprotein-Dependent Multidrug-Resistant Cells by Dihydro-β-agarofuran Sesquiterpenes from Celastrus vulcanicola. Journal of natural products. 2015 Apr; 78(4):736-45. doi: 10.1021/np500903a. [PMID: 25695368]
  • Soumaya Anoun, Mouna Lamchahab, Bouchra Oukkache, Maryam Qachouh, Said Benchekroun, Asmaa Quessar. Acquired factor VII deficiency associated with acute myeloid leukemia. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 2015 Apr; 26(3):331-3. doi: 10.1097/mbc.0000000000000024. [PMID: 24991944]